Physician profile
Jeffrey E Gretz
NPI 1306931209
$798.93
in general payments reported to CMS, 2019-2025
12 companies · $57.19 in 2025
The $57.19 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $79.95 · 2022: $194 · 2023: $23.79 · 2024: $322 · 2025: $57.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.48 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $143.22 | 2024 | |
| Janssen Biotech, INC. | $79.95 | 2020 | |
| Alexion Pharmaceuticals, INC. | $35.00 | 2024 | Ultomiris |
| Braintree Laboratories, INC. | $29.40 | 2019 | |
| Gilead Sciences, INC. | $25.60 | 2024 | |
| Olympus America INC. | $22.18 | 2025 | Single Use Aspiration Needle Na-U200h |
| Alnylam Pharmaceuticals INC. | $16.61 | 2024 | Onpattro |
| Phathom Pharmaceuticals, INC. | $16.25 | 2024 | Voquezna |
| Tandem Diabetes Care, INC. | $15.43 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Exact Sciences Corporation | $14.60 | 2024 | Cologuard Collection Kit |
| Tg Therapeutics, INC. | $13.21 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Gretz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.